Verified peer comparison
JNJ vs LLY
Johnson & Johnson compared with Eli Lilly and Company. This page compares both source-verified company profiles and does not introduce an unverified price target.
JNJ
Johnson & Johnson
$189.43
- Open
- --
- High
- --
- Low
- --
- Market Cap
- --
LLY
Eli Lilly and Company
$782.10
- Open
- --
- High
- --
- Low
- --
- Market Cap
- --
Company-specific comparison
Business exposure
JNJ: Pharmaceuticals
LLY: Pharmaceuticals
Upside lens
JNJ: Growth from newer and expanding oncology, immunology, and neuroscience medicines can offset erosion in mature products. Higher procedure volumes and adoption of newer cardiovascular, surgery, orthopaedics, and vision technologies can support MedTech growth. Regulatory approvals, label expansions, and clinical readouts across medicine and MedTech can create additional durable revenue streams.
LLY: obesity drug adoption and pipeline expansion
Risk lens
JNJ: Pending talc claims create uncertain legal costs, potential judgments, and reputational exposure that may persist despite defense and resolution efforts. Biosimilar or generic competition, government price negotiations, and payer pressure can reduce sales and margins for key medicines. Pipeline assets and medical devices may fail trials, face approval delays, encounter safety findings, or fall short of commercial adoption expectations.
LLY: supply constraints and valuation expectations
Verified sources
Johnson & Johnson 2026 First-Quarter ResultsJohnson & Johnson · earningsVerified
Johnson & Johnson Investor RelationsJohnson & Johnson · companyVerified
Fetched: 7/12/2026, 12:00:00 AM UTC
Open original sourceJohnson & Johnson Form 10-Q for the fiscal quarter ended March 29, 2026U.S. Securities and Exchange Commission · filingVerified
Lilly Reports First-Quarter 2026 Financial ResultsEli Lilly and Company · earningsVerified
Eli Lilly Investor RelationsEli Lilly and Company · companyVerified
Fetched: 7/11/2026, 12:00:00 AM UTC
Open original sourceForm 10-Q for the Quarter Ended March 31, 2026Eli Lilly and Company · filingVerified
LLY editorial research profileAlphaVue Research · editorialVerified
Fetched: 7/11/2026, 12:00:00 AM UTC